{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:11:04Z","timestamp":1789168264578,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: The potential therapeutic role of fecal microbiota transplantation (FMT) in various diseases has been thoroughly studied over the last few decades. However, the majority of studies focus on the adult population, therefore, conclusions regarding the application of FMT in the pediatric population are much less clear. This systematic review aims to summarize the research conducted so far on the efficacy and safety of FMT in the pediatric population, assess the quality of the evidence of its effectiveness, and outline the most promising areas for future research. Methods: We performed a systematic literature search from the index date to 8 June 2024 on the Embase, PubMed, and Web of Science databases. One author screened the resulting 121 articles. Eventually, 35 eligible studies that reported FMT use in seven different diseases were identified. Results: All of the studies assessed FMT as a safe procedure without many serious adverse effects. The best-documented application, which is the only one recommended in official guidelines, is recurrent Clostridioides difficile infection. Other disease entities in which the use of FMT has been studied with good clinical effects are inflammatory bowel disease, allergic colitis, autism, Tourette syndrome, and colonization with multi-drug-resistant organisms. However, it should be noted that the majority of studies are cohort and case-control studies, without randomization, which translates into low evidence quality. In one randomized, controlled trial focusing on the effect of FMT on weight loss in obese individuals, a lack of effect was found. Conclusions: While FMT and subsequent iterations of gut microbiota-targeted interventions hold promising therapeutic potential for various disease entities in the pediatric population, the current evidence behind this conclusion is of low quality. Based on current studies, these methods appear to be both effective and safe. However, further randomized clinical trials are necessary, especially within the pediatric population, for which such studies remain scarce.<\/jats:p>","DOI":"10.3390\/biomedicines13061393","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:52:28Z","timestamp":1749181948000},"page":"1393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Possible Applications of Fecal Microbiota Transplantation in the Pediatric Population: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-8133","authenticated-orcid":false,"given":"Ewa A.","family":"Bieganska","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-7560","authenticated-orcid":false,"given":"Przemyslaw","family":"Kosinski","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-1915","authenticated-orcid":false,"given":"Marek","family":"Wolski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00432-022-04546-5","article-title":"Gut microbiota: A potential target for improved cancer therapy","volume":"149","author":"Zhao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.14336\/AD.2022.1127","article-title":"Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer\u2019s Disease: A Systematic Review","volume":"14","author":"Zou","year":"2023","journal-title":"Aging Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.dld.2023.11.015","article-title":"Microbiota and IBD: Current knowledge and future perspectives","volume":"56","author":"Foppa","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"122748","DOI":"10.1016\/j.lfs.2024.122748","article-title":"Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights","volume":"350","author":"Zali","year":"2024","journal-title":"Life Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MCO.0000000000001028","article-title":"Microbiome and its impact on fetal and neonatal brain development: Current opinion in pediatrics","volume":"27","author":"Frerichs","year":"2024","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liang, S., Wu, X., and Jin, F. (2018). Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis. Front. Integr. Neurosci., 12.","DOI":"10.3389\/fnint.2018.00033"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/MCG.0000000000000244","article-title":"Fecal microbiota transplantation: A new old kid on the block for the management of gut microbiota-related disease","volume":"48","author":"Cammarota","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.18773\/austprescr.2020.014","article-title":"Faecal microbiota transplantation: Indications, evidence and safety","volume":"43","author":"Soo","year":"2020","journal-title":"Aust. Prescr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.mayocp.2019.08.006","article-title":"Update on Treatment of Clostridioides difficile Infection","volume":"95","author":"Cho","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0000000000002205","article-title":"Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"68","author":"Davidovics","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2023-331550","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: Second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines","volume":"73","author":"Mullish","year":"2024","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst. Rev."},{"key":"ref_15","unstructured":"(2024, July 08). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2023062307","DOI":"10.1542\/peds.2023-062307","article-title":"Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy","volume":"152","author":"Shirley","year":"2023","journal-title":"Pediatrics"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tun, K.M., Hsu, M., Batra, K., Lo, C.H., Laeeq, T., Vongsavath, T., Mohammed, S., and Hong, A.S. (2022). Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of Clostridioides difficile Infection among Pediatric Patients: A Systematic Review and Meta-Analysis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122450"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MCG.0000000000001633","article-title":"Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease A Systematic Review and Meta-analysis","volume":"57","author":"Tariq","year":"2023","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102604","DOI":"10.1016\/j.eclinm.2024.102604","article-title":"Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update","volume":"72","author":"Patel","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1200\/JCO.18.00407","article-title":"Guideline for the Management of Clostridium difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients","volume":"36","author":"Diorio","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1093\/jpids\/pix076","article-title":"Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients","volume":"7","author":"Bluestone","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3324\/haematol.2019.244210","article-title":"Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: Gut microbiota profiling, infectious and clinical outcomes","volume":"105","author":"Merli","year":"2020","journal-title":"Haematologica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory Bowel Disease in Children and Adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ismej.2013.80","article-title":"Dysbiosis in inflammatory bowel diseases: The oxygen hypothesis","volume":"7","year":"2013","journal-title":"ISME J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/ajg.2012.335","article-title":"Microbiota ofDe-NovoPediatric IBD: IncreasedFaecalibacterium Prausnitziiand Reduced Bacterial Diversity in Crohn\u2019s But Not in Ulcerative Colitis","volume":"107","author":"Hansen","year":"2012","journal-title":"Off. J. Am. Coll. Gastroenterol.|ACG"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e030120","DOI":"10.1136\/bmjopen-2019-030120","article-title":"Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn\u2019s disease population: PediCRaFT Trial","volume":"9","author":"Pai","year":"2019","journal-title":"BMJ Open"},{"key":"ref_27","first-page":"718","article-title":"Protocol and preliminary feasibility results of the first pilot randomized-controlled trial of fecal microbiota transplant for pediatric Crohn\u2019s disease","volume":"72","author":"Hill","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.gastro.2021.04.067","article-title":"Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects","volume":"161","author":"Pai","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S-132","DOI":"10.1016\/S0016-5085(20)31009-X","article-title":"616 Results of the first paediatric randomized-controlled trial of faecal microbiota transplant for ulcerative colitis","volume":"158","author":"Pai","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_30","first-page":"S498","article-title":"Impact of fecal microbiota transplantation on gut microbiota diversity and clinical outcomes in pediatric ulcerative colitis: A partially double-blind randomized controlled trial","volume":"77","author":"Le","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ibd\/izx035","article-title":"Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children with Inflammatory Bowel Disease","volume":"24","author":"Goyal","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_32","first-page":"81","article-title":"A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease","volume":"1047","author":"Grzesiowski","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/00054725-201212001-00161","article-title":"Fecal microbial transplantation shows efficacy in children with refractory ulcerative colitis-early results of phase i clinical trial","volume":"18","author":"Kunde","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MPG.0b013e318292fa0d","article-title":"Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis","volume":"56","author":"Kunde","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MIB.0000000000000307","article-title":"Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn\u2019s disease","volume":"21","author":"Suskind","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_36","first-page":"CD012774","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","volume":"11","author":"Imdad","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hsu, M., Tun, K.M., Batra, K., Haque, L., Vongsavath, T., and Hong, A.S. (2023). Safety and Efficacy of Fecal Microbiota Transplantation in Treatment of Inflammatory Bowel Disease in the Pediatric Population: A Systematic Review and Meta-Analysis. Microorganisms, 11.","DOI":"10.3390\/microorganisms11051272"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The Central Nervous System and the Gut Microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., and Calabr\u00f2, A. (2017). New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome, 5.","DOI":"10.1186\/s40168-017-0242-1"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kang, D.W., Adams, J.B., Coleman, D.M., Pollard, E.L., Maldonado, J., McDonough-Means, S., Caporaso, J.G., and Krajmalnik-Brown, R. (2019). Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-42183-0"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kang, D.W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., and McDonough-Means, S. (2017). Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome, 5.","DOI":"10.1186\/s40168-016-0225-7"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., Tang, W., Chen, L., Chen, M., and Lv, L. (2021). Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.759435"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Pan, Z.Y., Zhong, H.J., Huang, D.N., Wu, L.H., and He, X.X. (2022). Beneficial Effects of Repeated Washed Microbiota Transplantation in Children with Autism. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.928785"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"AB512","DOI":"10.1016\/j.gie.2019.03.857","article-title":"Mo1667 fecal microbiota transplantation for children with autism spectrum disorder","volume":"89","author":"Zhao","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhu, G., Wan, L., Liang, Y., Liu, X., Yan, H., Zhang, B., and Yang, G. (2023). Effect of fecal microbiota transplantation in children with autism spectrum disorder: A systematic review. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1123658"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.3748\/wjg.v23.i48.8570","article-title":"Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, H.J., Luo, X., Shi, Y.C., Li, J.F., Pan, F., Ren, R.R., Peng, L.H., Shi, X.Y., Yang, G., and Wang, J. (2020). The Efficacy of Fecal Microbiota Transplantation for Children with Tourette Syndrome: A Preliminary Study. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.554441"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2030415","DOI":"10.1001\/jamanetworkopen.2020.30415","article-title":"Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial","volume":"3","author":"Leong","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110727","DOI":"10.1016\/j.nut.2020.110727","article-title":"Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora","volume":"73","author":"Michels","year":"2020","journal-title":"Nutrition"},{"key":"ref_51","first-page":"186","article-title":"Fecal microbiota transplantation in the treatment of acute gastrointestinal graft-versus-host disease: A retrospective survey of the transplant complications working party of EBMT","volume":"57","author":"Bilinski","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","article-title":"Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms","volume":"72","author":"Ghani","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Innes, A.J., Mullish, B.H., Ghani, R., Szydlo, R.M., Apperley, J.F., Olavarria, E., Palanicawandar, R., Kanfer, E.J., Milojkovic, D., and McDonald, J.A.K. (2021). Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized with Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.684659"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zeng, L., Deng, Y., Yang, K., Chen, J., He, Q., and Chen, H. (2022). Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.944387"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: The global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.12998\/wjcc.v6.i161.1121","article-title":"Safety of fecal microbiota transplantation in Chinese children: A single-center retrospective study","volume":"6","author":"Zhang","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ecco-jcc\/jjaa170","article-title":"Re-Evaluating the Evidence for Faecal Microbiota Transplantation \u2018Super-Donors\u2019 in Inflammatory Bowel Disease","volume":"15","author":"Olesen","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10620-024-08351-7","article-title":"Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota","volume":"69","author":"Sadowsky","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2017.03.011","article-title":"Fecal microbiota transplantation (FMT) could reverse the severity of experimental necrotizing enterocolitis (NEC) via oxidative stress modulation","volume":"108","author":"Li","year":"2017","journal-title":"Free Radic Biol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpedsurg.2020.02.035","article-title":"Fecal microbiota transplantation by enema reduces intestinal injury in experimental necrotizing enterocolitis","volume":"55","author":"Liu","year":"2020","journal-title":"J. Pediatr. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jpedsurg.2018.10.045","article-title":"The protective effects of fecal microbiota transplantation in an experimental model of necrotizing enterocolitis","volume":"54","author":"Prado","year":"2019","journal-title":"J. Pediatr. Surg."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:26Z","timestamp":1760032046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biomedicines13061393"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13061393","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}